The Firm advised leading pharma group Benta on the US$30 Million joint-venture with a prominent Egyptian pharma group to build and operate a high capacity drug manufacture. | Abou Jaoude & Associates
The Firm advised leading pharma group Benta on the US$30 Million joint-venture with a prominent Egyptian pharma group to build and operate a high capacity drug manufacture.
December 2011
The Firm advised leading pharma group Benta on the US$30 Million joint-venture with a prominent Egyptian pharma group to build and operate a high capacity drug manufacture.
The Firm represented the purchaser on the multi-million dollar acquisition of an equity stake in a real estate company with the aim of developing a touristic project, including advice on the post-acquisition financing of the project.
